Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Ankur Kalra and Amy Nowacki.
Ankur Kalra
Connection Strength
0.399
Amy Nowacki
  1. Angiotensin-Converting Enzyme Inhibitors Versus Angiotensin II Receptor Blockers: A Comparison of Outcomes in Patients With COVID-19. Circ Cardiovasc Qual Outcomes. 2020 10; 13(10):e007115.
    View in: PubMed
    Score: 0.225
  2. Renin-angiotensin system blockers, risk of SARS-CoV-2 infection and outcomes from CoViD-19: systematic review and meta-analysis. Eur Heart J Cardiovasc Pharmacother. 2022 02 16; 8(2):165-178.
    View in: PubMed
    Score: 0.062
  3. Association of Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Testing Positive for Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020 09 01; 5(9):1020-1026.
    View in: PubMed
    Score: 0.056
  4. Incidence of Stress Cardiomyopathy During the Coronavirus Disease 2019 Pandemic. JAMA Netw Open. 2020 07 01; 3(7):e2014780.
    View in: PubMed
    Score: 0.056
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.